Arteris (AIP) to Announce Quarterly Earnings on Thursday

Key Points

• Arteris is expected to report Q2 2026 results after the market closes on August 6, with analysts forecasting a loss of $0.05 per share and revenue of approximately $23.5 million.
• The company exceeded expectations in its prior quarter, reporting a $0.03-per-share loss versus the anticipated $0.08 loss and revenue of $22.94 million versus the $21.03 million estimate.
• Analysts have a consensus “Hold” rating and an average price target of $38.20, while insiders have sold approximately $51.0 million of shares over the past 90 days.

Arteris (NASDAQ:AIP - Get Free Report) will likely be releasing its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect the company to post earnings of ($0.05) per share and revenue of $23.4790 million for the quarter. Investors can check the company's upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, August 6, 2026 at 4:30 PM ET.

Arteris (NASDAQ:AIP - Get Free Report) last released its quarterly earnings results on Tuesday, May 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.08) by $0.05. The firm had revenue of $22.94 million during the quarter, compared to analysts' expectations of $21.03 million. On average, analysts expect Arteris to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Arteris Stock Performance

Shares of AIP opened at $26.96 on Thursday. The firm has a market capitalization of $1.24 billion, a P/E ratio of -34.13 and a beta of 1.92. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.73 and a quick ratio of 0.73. Arteris has a one year low of $8.42 and a one year high of $50.26. The business has a fifty day moving average of $36.79 and a 200 day moving average of $25.60.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on AIP shares. Oppenheimer initiated coverage on Arteris in a research report on Thursday, July 16th. They issued an "outperform" rating and a $40.00 target price on the stock. Northland Securities set a $38.00 price target on shares of Arteris in a research report on Wednesday, May 13th. Jefferies Financial Group increased their price objective on shares of Arteris from $16.00 to $35.00 and gave the stock a "hold" rating in a research note on Wednesday, May 13th. TD Cowen raised their price objective on shares of Arteris from $22.00 to $40.00 and gave the stock a "buy" rating in a report on Wednesday, May 13th. Finally, Wall Street Zen lowered shares of Arteris from a "buy" rating to a "hold" rating in a research report on Saturday, May 2nd. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average price target of $38.20.

Insider Buying and Selling

In other Arteris news, major shareholder Bayview Legacy, Llc sold 192,686 shares of the firm's stock in a transaction that occurred on Thursday, July 2nd. The shares were sold at an average price of $36.32, for a total transaction of $6,998,355.52. Following the sale, the insider owned 8,555,047 shares in the company, valued at approximately $310,719,307.04. This trade represents a 2.20% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Saiyed Atiq Raza sold 90,000 shares of Arteris stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $28.71, for a total transaction of $2,583,900.00. Following the transaction, the director directly owned 210,000 shares in the company, valued at $6,029,100. This represents a 30.00% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 1,459,949 shares of company stock worth $50,978,726 over the last ninety days. 23.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of AIP. Raymond James Financial Inc. bought a new stake in Arteris during the second quarter valued at about $32,000. BNP Paribas Financial Markets lifted its position in shares of Arteris by 75.0% in the third quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company's stock valued at $61,000 after acquiring an additional 2,595 shares in the last quarter. Strs Ohio bought a new position in shares of Arteris in the first quarter worth about $104,000. Susquehanna Fundamental Investments LLC bought a new position in shares of Arteris in the third quarter worth about $113,000. Finally, New York State Common Retirement Fund grew its position in shares of Arteris by 352.4% during the fourth quarter. New York State Common Retirement Fund now owns 9,500 shares of the company's stock worth $147,000 after purchasing an additional 7,400 shares in the last quarter. Institutional investors own 64.36% of the company's stock.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.